Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Zebularine improved skin structure but delayed wound healing in diabetic mice.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Baricitinib may effectively treat oral lichen planus.

Bazi Bushen capsules reduce skin aging and damage from UV rays.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Bifidobacterium animalis subsp. lactis J12 helps reduce atopic dermatitis symptoms.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Baricitinib may effectively treat lichen planopilaris.

Spanlastic-laden nanogel could be a better way to deliver hair growth medication through the skin for treating hair loss.

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Both 0.01% and 0.03% bimatoprost safely improve eyebrow fullness, with a patient preference for the 0.03% concentration.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

The patch effectively promotes hair growth for alopecia areata without pain.

A3B5 can reduce skin pigmentation and slow melanoma growth.